RTX (RTX) Is Up 6.0% After US$1.10 Billion Navy Missile Deal And Index Exit - Has The Bull Case Changed?
RAYTHEON TECHNOLOGIES CORPORATION RTX | 0.00 |
- In late June 2026, RTX’s Raytheon business secured a US$1.10 billion contract from the U.S. Navy to produce AIM-9X Block II missiles, alongside a reaffirmed quarterly dividend of US$0.73 per share and a subsequent removal of RTX from the Russell 1000 Dynamic Index.
- The sizeable AIM-9X award, coupled with plans to lift missile output to 2,500 units annually, underscores how defense demand and production scaling are increasingly central to RTX’s mix of risks and opportunities.
- We’ll now examine how this US$1.10 billion AIM-9X Navy contract may reshape RTX’s investment narrative around defense growth and execution.
Find 44 companies with promising cash flow potential yet trading below their fair value.
RTX Investment Narrative Recap
To own RTX today, you need to be comfortable with a business that leans heavily on large, long-duration defense programs while still carrying meaningful engine and cost risks. The US$1.10 billion AIM-9X contract reinforces defense as the key short term catalyst, though it does not change the fact that tariff exposure and Pratt & Whitney reliability issues remain the biggest swing factors for earnings and cash flow.
Among recent updates, the reaffirmed US$0.73 quarterly dividend sits alongside RTX’s raised 2026 guidance for 5% to 6% organic sales growth, which many investors watch as a yardstick for execution on its defense and aerospace backlog. Together with the AIM-9X award, these developments keep attention squarely on whether RTX can turn its record contract wins into consistent margins despite input cost and program risk.
Yet alongside these contract wins, investors should be aware that ongoing Pratt & Whitney engine reliability and aftermarket cost risks could still...
RTX's narrative projects $108.1 billion revenue and $10.2 billion earnings by 2029. This requires 6.1% yearly revenue growth and about a $2.9 billion earnings increase from $7.3 billion today.
Uncover how RTX's forecasts yield a $215.73 fair value, a 8% upside to its current price.
Exploring Other Perspectives
Three fair value estimates from the Simply Wall St Community cluster between US$197.48 and US$215.73, highlighting how differently individual investors view RTX. Set against this, the AIM-9X contract as a key defense catalyst raises important questions about how future government ordering patterns could affect RTX’s ability to sustain growth and profitability.
Explore 3 other fair value estimates on RTX - why the stock might be worth just $197.48!
Reach Your Own Conclusion
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your RTX research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
- Our free RTX research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate RTX's overall financial health at a glance.
Want Some Alternatives?
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
- Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
